Dzyurkevich M.; Babkov D.; Shtyrlin N.; Mayka O.; Iksanova A.; Vassiliev P.; Balakin K.; Spasov A.; Tarasov V.; Barreto G.; Shtyrlin Y.; Aliev G.
(2017)
© 2017 The Author(s). Glucokinase is one of the promising targets for glucose-lowering agents, and the development of GK activators are now considered as one of the most promising strategies for the treatment of type 2 ...